Fulcrum Capital LLC Edwards Lifesciences Corp Transaction History

Fulcrum Capital LLC

$432 Million
Q2 2024

A detailed history of Fulcrum Capital LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fulcrum Capital LLC holds 113,838 shares of EW stock, worth $7.45 Million. This represents 2.43% of its overall portfolio holdings.

Number of Shares

113,838

Previous 113,571 0.24%

Holding current value

$7.45 Million

Previous $10.9 Million 3.11%

% of portfolio

2.43%

Previous 2.62%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$84.3 - $94.31 $22,508 - $25,180	267 Added 0.24%	113,838 $10.5 Million
Q1 2024 Apr 17, 2024	BUY	$72.54 - $95.56 $34,746 - $45,773	479 Added 0.42%	113,571 $10.9 Million
Q4 2023 Jan 10, 2024	BUY	$61.71 - $77.76 $1.18 Million - $1.48 Million	19,096 Added 20.32%	113,092 $8.62 Million
Q3 2023 Oct 13, 2023	BUY	$69.28 - $93.38 $22,308 - $30,068	322 Added 0.34%	93,996 $6.51 Million
Q2 2023 Jul 27, 2023	SELL	$81.41 - $94.33 $249,847 - $289,498	-3,069 Reduced 3.17%	93,674 $8.84 Million
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $522,344 - $594,443	7,034 Added 7.84%	96,743 $8 Million
Q4 2022 Jan 24, 2023	BUY	$68.3 - $87.44 $439,783 - $563,026	6,439 Added 7.73%	89,709 $0
Q3 2022 Oct 17, 2022	SELL	$82.37 - $107.29 $204,854 - $266,830	-2,487 Reduced 2.9%	83,270 $6.88 Million
Q2 2022 Aug 03, 2022	SELL	$86.5 - $128.27 $104,838 - $155,463	-1,212 Reduced 1.39%	85,757 $8.16 Million
Q1 2022 May 05, 2022	BUY	$101.96 - $128.34 $78,917 - $99,335	774 Added 0.9%	86,969 $10.2 Million
Q4 2021 Jan 25, 2022	BUY	$106.37 - $130.68 $110,518 - $135,776	1,039 Added 1.22%	86,195 $11.2 Million
Q3 2021 Oct 21, 2021	BUY	$102.91 - $122.75 $10,908 - $13,011	106 Added 0.12%	85,156 $9.64 Million
Q2 2021 Jul 30, 2021	BUY	$83.84 - $104.76 $192,832 - $240,948	2,300 Added 2.78%	85,050 $8.81 Million
Q1 2021 Apr 12, 2021	BUY	$78.68 - $90.67 $271,760 - $313,174	3,454 Added 4.36%	82,750 $6.92 Million
Q4 2020 Feb 09, 2021	BUY	$71.69 - $91.23 $268,765 - $342,021	3,749 Added 4.96%	79,296 $7.23 Million
Q3 2020 Oct 21, 2020	SELL	$67.19 - $87.44 $455,279 - $592,493	-6,776 Reduced 8.23%	75,547 $6.03 Million
Q2 2020 Jul 27, 2020	BUY	$57.54 - $76.95 $3.07 Million - $4.11 Million	53,395 Added 184.58%	82,323 $5.69 Million
Q1 2020 May 01, 2020	BUY	$52.41 - $81.0 $5,765 - $8,910	110 Added 0.38%	28,928 $5.46 Million
Q4 2019 Feb 03, 2020	BUY	$71.7 - $82.09 $5,305 - $6,074	74 Added 0.26%	28,818 $6.72 Million
Q3 2019 Oct 31, 2019	SELL	$61.55 - $75.43 $1,661 - $2,036	-27 Reduced 0.09%	28,744 $7.69 Million
Q2 2019 Jul 29, 2019	BUY	$55.74 - $64.41 $349,043 - $403,335	6,262 Added 27.82%	28,771 $5.32 Million
Q1 2019 May 08, 2019	BUY	$47.89 - $64.05 $31,846 - $42,593	665 Added 3.04%	22,509 $4.31 Million
Q4 2018 Feb 12, 2019	BUY	$46.41 - $56.94 $60,797 - $74,591	1,310 Added 6.38%	21,844 $3.35 Million
Q3 2018 Nov 06, 2018	BUY	$45.7 - $58.03 $21,753 - $27,622	476 Added 2.37%	20,534 $3.58 Million
Q2 2018 Aug 03, 2018	BUY	$42.45 - $51.3 $851,462 - $1.03 Million	20,058 New	20,058 $2.92 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Capital LLC with notifications on news.

Account

Fulcrum Capital LLC Edwards Lifesciences Corp Transaction History